[144] Vital Farms, Inc. SEC Filing

Rhea-AI Filing Summary

Vital Farms, Inc. filed a Form 144 reporting a proposed sale of 20,000 common shares through J.P. Morgan Securities LLC on Nasdaq with an approximate sale date of 08/13/2025. The filing lists an aggregate market value of $924,200 and shows 44,685,980 shares outstanding.

The securities were acquired on 01/06/2015 in a private transaction from the issuer, with an original acquisition amount of 129,230 shares and payment dated 01/06/2015. The filing reports "Nothing to Report" for securities sold in the past three months. The document includes the standard certification that the filer does not know of any undisclosed material adverse information; certain fields such as the filer relationship to the issuer and the notice date are not specified in the provided text.

Insights

Securities Analyst

TL;DR: Form 144 reports a planned sale of 20,000 common shares valued at $924,200; filing appears procedural and not materially impactful.

The filing documents a proposed sale executed through J.P. Morgan Securities LLC on Nasdaq with an approximate sale date of 08/13/2025 and an aggregate market value of $924,200. The issuer's outstanding shares are listed as 44,685,980 and there are no reported sales by the filer in the past three months. Acquisition details show the shares were purchased 01/06/2015 in a private transaction from the issuer (129,230 shares acquired). Based solely on the facts in the filing, the transaction appears routine and the document fulfils disclosure requirements under Rule 144.

Corporate Governance Expert

TL;DR: Disclosure demonstrates Rule 144 compliance; several contextual fields (relationship to issuer, notice date) are blank in the provided text.

The form includes the required representation that the filer is unaware of undisclosed material adverse information and specifies acquisition history and payment dates. The filing lists the broker, approximate sale date, aggregate market value, and outstanding share count. However, fields such as the filer relationship to the issuer and the date of notice are not populated in the provided content, limiting context about the filer 's connection to company insiders or affiliates. Based strictly on provided information, this is a standard disclosure without material governance implications shown in the text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 390 Madison Avenue - 6th Floor New York NY 10017	20000	924200	44685980	08/13/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/06/2015	Private Transaction	Issuer			129230	01/06/2015	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does Vital Farms (VITL) intend to sell?

The filing reports the proposed sale of 20,000 common shares on Nasdaq via J.P. Morgan Securities LLC with an aggregate market value of $924,200.

When is the approximate sale date listed in the Form 144 for VITL?

The approximate date of sale is listed as 08/13/2025 in the filing.

How and when were the securities being sold originally acquired?

The securities were acquired on 01/06/2015 in a private transaction from the issuer; the acquisition amount is shown as 129,230 shares and payment dated 01/06/2015.

Has the filer sold any Vital Farms securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 indicate the filer 's relationship to Vital Farms?

The provided content does not specify the filer 's relationship to the issuer; that field is not populated in the text supplied.

Does the filing include the filer's certification about material adverse information?

Yes, the document includes the standard representation that the filer does not know of any material adverse information about the issuer that has not been publicly disclosed.